News

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.
The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.
It comes after the U.S. Health Secretary Robert F. Kennedy Jr. dismissed all members of the CDC's vaccine advisory committee, ...
The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...